Andrew I'm not overly concerned about obtaining tissue specific absorption with systemic administration. Too difficult to achieve. The alternative is to deliver a promising choice via direct arterial organ cannulation as with dye injection for angiograms, though repeated administration could be an issue under that scenario.
Are there any drugs currently in use that have organ/tissue specific pharmacokinetics that do not depend on cell receptors?
- Forums
- ASX - By Stock
- PYC
- Ann: CEO letter and Operational Update
Ann: CEO letter and Operational Update, page-17
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $513.2M |
Open | High | Low | Value | Volume |
10.5¢ | 11.0¢ | 10.5¢ | $355.5K | 3.310M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 47619 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 720205 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 47619 | 0.105 |
29 | 2401904 | 0.100 |
2 | 76315 | 0.097 |
1 | 10000 | 0.096 |
8 | 1404743 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 720205 | 5 |
0.115 | 446302 | 5 |
0.120 | 987215 | 9 |
0.125 | 2090479 | 7 |
0.130 | 583324 | 4 |
Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
Last
11.0¢ |
  |
Change
0.005 ( 4.76 %) |
|||
Open | High | Low | Volume | ||
10.8¢ | 11.0¢ | 10.3¢ | 1399972 | ||
Last updated 15.49pm 29/05/2024 ? |
Featured News
PYC (ASX) Chart |